Representative lipid-based delivery systems and formulation applications supported by APS expertise.
Lipid Nanoparticles (LNPs)
mRNA, siRNA, gene editing and other nucleic-acid therapies.
Solid Lipid Nanoparticles (SLNs)
Improved drug stability, controlled release and targeted delivery.
Liposomes, Emulsions & Nanoemulsions
Topical, parenteral, ophthalmic and other formulation platforms.
Lipid–Drug Conjugates
Linker and lipid technologies for targeted therapies.
Vaccine Adjuvants
Lipid-based systems designed to enhance immune responses.
Nanostructured Lipid Carriers (NLCs)
Hybrid solid/liquid lipid matrices for improved loading, stability and release control.